Michael Joseph Krowka
#144,600
Most Influential Person Now
Michael Joseph Krowka's AcademicInfluence.com Rankings
Michael Joseph Krowkaphilosophy Degrees
Philosophy
#7715
World Rank
#10965
Historical Rank
Logic
#4753
World Rank
#6080
Historical Rank

Download Badge
Philosophy
Why Is Michael Joseph Krowka Influential?
(Suggest an Edit or Addition)Michael Joseph Krowka's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension (2019) (2124)
- Diagnosis and differential assessment of pulmonary arterial hypertension. (2004) (999)
- Pulmonary–Hepatic vascular Disorders (PHD) (2004) (734)
- Hepatopulmonary syndrome--a liver-induced lung vascular disorder. (2008) (576)
- Pulmonary hemodynamics and perioperative cardiopulmonary‐related mortality in patients with portopulmonary hypertension undergoing liver transplantation (2000) (513)
- Natural history of hepatopulmonary syndrome: Impact of liver transplantation (2005) (415)
- Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. (2004) (398)
- Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database (2004) (389)
- Pulmonary complications of bone marrow transplantation. (1985) (388)
- Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin (1998) (356)
- Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation (2003) (353)
- Portopulmonary hypertension: Results from a 10‐year screening algorithm (2006) (316)
- Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. (1993) (288)
- Portopulmonary hypertension and hepatopulmonary syndrome (2004) (276)
- Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups (2008) (275)
- Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. (1994) (274)
- Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension (1999) (255)
- International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. (2016) (254)
- Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. (1996) (245)
- Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. (2008) (237)
- Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. (2000) (231)
- Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. (1998) (230)
- Hepatic hydrothorax: pathogenesis, diagnosis, and management. (1999) (226)
- Clinical risk factors for portopulmonary hypertension (2008) (225)
- Portopulmonary hypertension: a report from the US-based REVEAL Registry. (2012) (222)
- Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. (1990) (214)
- Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. (1997) (209)
- Updated clinical classification of pulmonary hypertension. (2009) (197)
- Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. (2009) (194)
- Accuracy of doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates (2000) (183)
- Unexplained pulmonary hypertension in chronic myeloproliferative disorders. (2001) (175)
- Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. (1996) (174)
- Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation (1990) (168)
- Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. (2002) (168)
- Cardiac dysrhythmia following pneumonectomy. Clinical correlates and prognostic significance. (1987) (153)
- Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. (2008) (140)
- Pulmonary aspects of chronic liver disease and liver transplantation. (1985) (132)
- Pulmonary Hypertension Is Associated With Reduced Patient Survival After Kidney Transplantation (2008) (128)
- Hepatopulmonary syndrome versus portopulmonary hypertension: Distinctions and dilemmas (1997) (128)
- Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. (1990) (124)
- Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era (2013) (123)
- Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate. (1987) (120)
- Severe hypoxemia and liver disease. (1989) (116)
- Pulmonary aspects of liver disease and liver transplantation. (1989) (112)
- Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. (1995) (111)
- Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. (2011) (109)
- The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. (2005) (107)
- Effect of effort on measurement of forced expiratory volume in one second. (1987) (101)
- Pulmonary hypertension in patients with interstitial lung diseases. (2007) (97)
- Pulmonary arteriovenous malformations. (2013) (95)
- Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. (2013) (93)
- Model for end‐stage liver disease (MELD) exception for hepatopulmonary syndrome (2006) (93)
- Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. (2004) (89)
- Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. (1999) (86)
- Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment. (2004) (84)
- Hepatopulmonary syndromes (2000) (83)
- Hepatopulmonary syndrome and portopulmonary hypertension (2001) (81)
- Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial. (2019) (78)
- Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. (2010) (76)
- Model for end‐stage liver disease (MELD) exception for portopulmonary hypertension (2006) (75)
- Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding (2018) (75)
- Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). (2005) (74)
- A spectrum of pulmonary vascular pathology in portopulmonary hypertension (2000) (73)
- Hepatopulmonary syndrome: Recent literature (1997 to 1999) and implications for liver transplantation (2000) (70)
- Is severe arterial hypoxaemia due to hepatic disease an indication for liver transplantation? A new therapeutic approach. (1994) (70)
- An official American Thoracic Society Statement: pulmonary hypertension phenotypes. (2014) (68)
- Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. (2011) (65)
- Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. (1999) (65)
- Portopulmonary hypertension: state of the art. (2008) (63)
- Successful liver transplantation in patients with mild to moderate pulmonary hypertension. (1993) (62)
- Endothelium-derived relaxing factor in pulmonary and renal circulations during hypoxia. (1992) (60)
- Screen for portopulmonary hypertension, especially in liver transplant candidates. (2008) (59)
- Liver Transplantation for Hepatopulmonary Syndrome: A Ten-Year Experience in Paris, France. (2003) (57)
- Pulmonary Vascular Complications of Liver Disease. (2017) (54)
- Pulmonary hypertension: diagnostics and therapeutics. (2000) (52)
- The Prevalence of Alpha-1 Antitrypsin Deficiency Among Patients Found to Have Airflow Obstruction (2012) (51)
- Pulmonary complications of orthotopic liver transplantation. (1993) (49)
- Outcomes for recipients of liver transplantation for alpha‐1‐antitrypsin deficiency–related cirrhosis (2013) (49)
- Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension. (1999) (47)
- Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. (2005) (46)
- Predictors of Waitlist Mortality in Portopulmonary Hypertension (2017) (45)
- Clinical management of hepatopulmonary syndrome. (1993) (45)
- Evolving dilemmas and management of portopulmonary hypertension. (2006) (44)
- A prospective study of pulmonary function and gas exchange following liver transplantation. (1992) (41)
- Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. (2005) (41)
- Arterial oxygenation associated with portopulmonary hypertension. (2002) (39)
- North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. (2021) (38)
- Health‐related quality of life and survival in liver transplant candidates (2010) (36)
- Serotonin transporter polymorphisms in patients with portopulmonary hypertension. (2009) (35)
- Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation (2017) (35)
- Portopulmonary hypertension: Diagnostic advances and caveats (2003) (34)
- Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease. (2008) (33)
- Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation (2008) (32)
- Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival (2015) (29)
- Hepatopulmonary syndrome: what are we learning from interventional radiology, liver transplantation, and other disorders? (1995) (29)
- Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index. (2014) (29)
- Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia. (2016) (28)
- Formation of a national database on pulmonary hypertension and hepatopulmonary syndrome in chronic liver disease. (1997) (28)
- Azathioprine-associated pulmonary dysfunction. (1983) (28)
- Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience (2019) (27)
- Portopulmonary hypertension and the issue of survival (2005) (27)
- Doppler echocardiography-right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension. (2008) (27)
- Caveats concerning hepatopulmonary syndrome. (2001) (26)
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ILOPROST INHALATION IN ADULTS WITH ABNORMAL PULMONARY ARTERIAL PRESSURE AND EXERCISE LIMITATION ASSOCIATED WITH IDIOPATHIC PULMONARY FIBROSIS (2007) (26)
- Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation. (1999) (26)
- Treatment Barriers in Portopulmonary Hypertension (2018) (25)
- What’s new in the treatment of portopulmonary hypertension? (2015) (25)
- Inflammatory bowel diseases, chronic liver diseases and the lung (2016) (25)
- Portopulmonary Hypertension (2012) (24)
- Bronchogenic cyst causing atrial fibrillation by impinging the right inferior pulmonary vein. (2006) (23)
- How should we treat portopulmonary hypertension? (2006) (22)
- Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial. (2020) (22)
- Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation (2019) (22)
- Alpha 1-Antitrypsin Deficiency Carriers , Tobacco Smoke , Chronic Obstructive Pulmonary Disease , and Lung Cancer Risk (2008) (21)
- Primary biliary cirrhosis: Relation between hepatic function and pulmonary function in patients who never smoked (1991) (21)
- BMP 9/10 in Pulmonary Vascular Complications of Liver Disease. (2020) (21)
- Alpha1-Antitrypsin Deficiency Carriers, Serum Alpha 1-Antitrypsin Concentration, and Non-small Cell Lung Cancer Survival (2011) (20)
- Pulmonary hypertension, (high) risk of orthotopic liver transplantation, and some lessons from “primary” pulmonary hypertension (2002) (20)
- Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies (2018) (20)
- High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States. (2016) (20)
- Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double‐Blind, Placebo‐Controlled Trial (2019) (18)
- Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2) (2020) (18)
- Recent pulmonary observations in alpha 1-antitrypsin deficiency, primary biliary cirrhosis, chronic hepatitis C, and other hepatic problems. (1996) (18)
- A Pulmonary Vascular Complication of Liver Disease (1996) (18)
- Pulmonary Complications of Portal Hypertension. (2019) (17)
- Pathophysiology of arterial hypoxemia in advanced liver disease. (1996) (16)
- The impact of left ventricular hypertrophy on survival in candidates for liver transplantation (2014) (16)
- Portopulmonary hypertension. (2014) (16)
- Successful coil embolization of mediastinal bronchial artery aneurysm. (2010) (16)
- Liver Transplantation for Hepatopulmonary Syndrome (HPS): What Is the MESSAGE? (2008) (15)
- Management of pulmonary complications in pretransplant patients. (2011) (15)
- Hepatopulmonary syndrome. (2018) (15)
- Hepatopulmonary Syndrome: Monitoring at Your Fingertip (2011) (14)
- Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver Transplant (2017) (14)
- Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States. (2019) (14)
- Portopulmonary Hypertension: Understanding Pulmonary Hypertension in the Setting of Liver Disease (2004) (14)
- Agnogenic Myeloid Metaplasia with Pleural Extramedullary Leukemic Transformation (2004) (14)
- Portopulmonary hypertension. (2007) (14)
- Hepatopulmonary Disorders: Gas Exchange and Vascular Manifestations in Chronic Liver Disease. (2018) (13)
- Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension (2020) (13)
- Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes (2019) (13)
- Current Approach to the Diagnosis and Management of Portopulmonary Hypertension (2016) (12)
- Pulmonary alveolar proteinosis. (2012) (12)
- A prospective study of airway reactivity before bone marrow transplantation. (1990) (12)
- Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease (2020) (12)
- Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg (2020) (12)
- Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis (2020) (11)
- Hepatopulmonary syndrome and portopulmonary hypertension (2002) (10)
- Hepatopulmonary syndrome and liver transplantation (2000) (10)
- Portopulmonary hypertension: Formidable dual threat versus hopeful dual therapy (2014) (10)
- Hepatopulmonary syndrome and extrahepatic vascular abnormalities (2001) (10)
- Tracheal myxoma: a rare benign tracheal tumor. (2004) (9)
- The Myths and Realities of Portopulmonary Hypertension (2020) (9)
- Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry (2020) (9)
- Portopulmonary hypertension: the next step. (1997) (8)
- Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia-Related Bleeding and High-Output Cardiac Failure: Significant Inter-Individual Variability in the Need for Maintenance Therapy. (2020) (8)
- Transthoracic echocardiography screening for the detection of portopulmonary hypertension: A work in progress (2013) (8)
- Cardiovascular collapse induced by position-dependent pulmonary vein occlusion in a patient with fibrosing mediastinitis. (2005) (8)
- Plasma levels of S100A4 in portopulmonary hypertension (2009) (7)
- The distinct concepts and implications of hepatopulmonary syndrome and portopulmonary hypertension. (2005) (7)
- Effect of Center Volume on Outcomes in Hospitalized Patients With Hereditary Hemorrhagic Telangiectasia. (2016) (6)
- Liver and lung: Hepatopulmonary syndrome (2002) (6)
- Impact of Age on Outcomes in Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia (2018) (6)
- Subspecialty clinics : Pulmonary and critical care medicine : Hepatopulmonary syndrom with progressive hypoxemia as an indication for liver transplantation : Case reports and literature review (1997) (6)
- Survival benefits of liver transplant in severe hepatopulmonary syndrome. (2013) (6)
- Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy (1995) (6)
- Late Breaking Abstract - Efficacy and safety of macitentan in portopulmonary hypertension: the PORTICO trial (2018) (6)
- Gender Differences in Portopulmonary Hypertension. (2020) (5)
- Alpha 1-Antitrypsin Deficiency Allele Carriers among Lung Cancer Patients 1 (1999) (5)
- Arteriovenous malformations and hepatopulmonary syndrome (2004) (5)
- Editorial: Pulmonary hypertension, (high) risk of orthotopic liver transplantation, and some lessons from "primary" pulmonary hypertension. (2002) (5)
- Hepatopulmonary syndrome. (1993) (5)
- Outcomes of liver transplantation in patients with hepatopulmonary syndrome in the pre and post-MELD eras: A systematic review. (2021) (5)
- Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works (2017) (4)
- Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis (2021) (4)
- Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation. (2020) (4)
- Continuing medical education as viewed by medical students. (1979) (4)
- Portopulmonary hypertension and liver transplantation: A duo in question (2016) (4)
- Pulmonary Complications of Portal Hypertension (2019) (4)
- Bubble Trouble in COVID-19 (2020) (4)
- The Liver-Lung Vascular Connection (2017) (4)
- Many faces of portopulmonary hypertension. (2005) (3)
- Preoperative Assessment and Management of Liver Transplant Candidates With Portopulmonary Hypertension (2013) (3)
- Hepatopulmonary syndrome (2018) (3)
- Discordant alpha-1 antitrypsin phenotype and genotype results in a liver transplant patient. (2010) (3)
- Prevalence and Impact of Restrictive Lung Disease in Liver Transplant Candidates (2020) (3)
- Mending the MELD: An in-depth review of the past, present, and future portopulmonary hypertension MELD exception. (2022) (3)
- Portopulmonary hypertension: Diagnostic advances and caveats: Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study (2003) (3)
- Pulmonary Complications Associated with Portal Hypertension (2005) (3)
- ECMO and POPH: More Help for the Right Heart (2020) (2)
- ICU and Hospital Outcomes in Patients with Hepatopulmonary Syndrome Undergoing Liver Transplantation (2022) (2)
- INHALED NITRIC OXIDE REDUCES PULMONARY ARTERY PRESSURE IN PORTOPULMONARY HYPERTENSION (1998) (2)
- Pulmonary manifestations of chronic liver disease (2000) (2)
- 131 Pulmonary vascular complications of liver disease: survival analysis of 140 patients evaluated at mayo clinic (2003) (2)
- SEQUENTIAL HEPATOPULMONARY SYNDROME AND PORTOPULMONARY HYPERTENSION IN A LIVER TRANSPLANT CANDIDATE (2007) (2)
- Lung function and the complications of bone marrow transplantation. (1992) (2)
- Hepatopulmonary syndrome. (1991) (2)
- Identifying High Risk of Sleep-Disordered Breathing in Patients With Idiopathic Pulmonary Fibrosis (2010) (1)
- Portopulmonary hypertension: May we agree to disagree? (2023) (1)
- ICU and Hospital Outcomes of Patients with Hepatopulmonary Syndrome Undergoing Liver Transplantation (2020) (1)
- Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry. (2022) (1)
- Exploring the Spectrum of Pathology and Treatment in Portopulmonary Hypertension: Four Experts Address the Toughest Questions (2004) (1)
- Treatment of Portopulmonary Hypertension With Macitentan in Patients With Cirrhosis. (2019) (1)
- Improving hemodynamics pre-liver transplantation: The role of epoprostenol (2003) (1)
- Exercise-Echocardiography-Derived Pulmonary Artery Pressure Slope in Borderline and Mild to Moderate Pulmonary Arterial Hypertension (2008) (1)
- Liquid Chromatography-Tandem Mass Spectrometry-Based α1-Antitrypsin (AAT) Testing. (2020) (1)
- Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry. (2022) (1)
- Admission data: their use in health planning, legislative presentations, and premedical programs. (1981) (1)
- Liver and lung: How to manage portopulmonary hypertension (2002) (1)
- Hepatopulmonary syndrome. (1991) (1)
- Abstract 16424: Reliability and Validity of Grading of Intra-Pulmonary Shunting by Contrast Transthoracic Echocardiography in Hepatopulmonary Syndrome (2010) (1)
- Chapter 9 – Portopulmonary Hypertension (2006) (1)
- Hepatic and Biliary Disease (2012) (1)
- Pathology and Management of Portopulmonary Hypertension (2011) (1)
- Portopulmonary hypertension: A consequence of portal hypertension (2012) (1)
- Short and Long Termoxygenation Outcomes After Liver Transplantation for Hepatopulmonary Syndrome (2020) (1)
- An Empirical Approach to Projecting Regional Blood Need (1977) (0)
- Getting dark, too dark to see. Authors' reply (2005) (0)
- Portopulmonary Hypertension: Natural History, Medical Therapy, Transplantation, And Survival (2010) (0)
- 175 RISK FACTORS, INCIDENCE, AND TIME TO ONSET FOR THE DEVELOPMENT OF PULMONARY HYPERTENSION AFTER LIVER TRANSPLANTATION FOR HEPATOPULMONARY SYNDROME (2021) (0)
- Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception (2022) (0)
- Transplantation Anesthesia Hepatopulmonary SyndromeVA Liver-Induced Lung Vascular Disorder (2009) (0)
- P17 Pharmacokinetics of macitentan in patients with portopulmonary hypertension: findings from the PORTICO sub-study (2018) (0)
- Left Ventricular Diastolic Dysfunction in Advanced Liver Disease (2020) (0)
- Hemodynamics of Pulmonary Hypertension in the Setting of Hereditary Hemorrhagic Telangiectasia (2014) (0)
- Cardiopulmonary examination (2016) (0)
- Outcomes of Liver Transplantation for Hereditary Hemorrhagic Telangiectasia (HHT).: Abstract# C1969 (2014) (0)
- Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes (2022) (0)
- Quality of Life as Assessed by the SYMPACT Questionnaire in Patients with Chronic Thromboembolic Pulmonary Hypertension (2020) (0)
- Evidence Rofl umilast Reduces Severe Exacerbations (2015) (0)
- 19. Portopulmonary hypertension (2015) (0)
- Estrogen Metabolism in Portopulmonary Hypertension (POPH): A Case-Control Study (2019) (0)
- 1 Hepatopulmonary syndrome (2011) (0)
- Erratum: The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction (COPD: Journal of Chronic Obstructive Pulmonary Disease 9:4 (352-358)) (2013) (0)
- Pulmonary Alterations in Chronic Liver Failure (2011) (0)
- Hepatopulmonary syndrome: Long-term survival in the Mayo Clinic experience (2012) (0)
- Alpha-One Antitrypsin Deficiency: Survival And Pulmonary Function After Orthotopic Liver Transplantation In ZZ And SZ Phenotypes (2011) (0)
- The feasibility and value of assessing patient‐reported outcomes in pulmonary arterial hypertension (2022) (0)
- RISK FACTORS FOR COPD IN LIVER TRANSPLANT CANDIDATES (2007) (0)
- Role of Suppression of Tumorigenecity (ST2) in Pulmonary Vascular Complications of Liver Disease (2019) (0)
- CNS complications in pulmonary arteriovenous malformations: Response (2014) (0)
- Six-Minute walk distance predicts outcomes in liver transplant candidates (2023) (0)
- Relating health planning concepts to medical students. (1979) (0)
- Using PAH-SYMPACT to Assess Quality of Life in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease (2022) (0)
- Hepatocelluar and liver transplantation (2000) (0)
- Genetic Variation In Heme Oxygenase 1 Is Associated With Severity Of Oxygenation Abnormality In Patients With Hepatopulmonary Syndrome (2011) (0)
- Erratum: α1-antitrypsin and neutrophil elastase imbalance and lung cancer risk (Chest (July 2005) 128 (445-452)) (2006) (0)
- It's Complicated: Dyspnea and Hypoxemia in a Patient With Portal Hypertension (2023) (0)
- Hepatopulmonary Syndrome* ClinicalObservations andLackof Therapeutic ResponseToSomatostatin Analogue (2017) (0)
- Sex Differences in Portopulmonary Hypertension (2020) (0)
- Title: The Relationship Between Portopulmonary Hypertension and Splenectomy: Mayo Clinic Experience and Literature Review Short Title: Portopulmonary hypertension and splenectomy (2017) (0)
- LINICAL ADVANCES IN LIVER , PANCREAS , ND BILIARY TRACT mpact of Hepatopulmonary Syndrome on Quality of Life and Survival in iver Transplant Candidates (2008) (0)
- Hepatopulmonary syndrome [16] (1991) (0)
- Pulmonary Evaluation of Liver Transplant Candidates (2019) (0)
- PSEUDOMITRAL STENOSIS DUE TO PULMONARY VENOUS OBSTRUCTION BY NONCALCIFIED FIBROSING MEDIASTINITIS ASSOCIATED WITH HISTOPLASMOSIS (2006) (0)
- Severe Hypoxemia and Liver Disease (1990) (0)
- ELECTROCARDIOGRAPHIC CHARACTERISTICS OF PULMONARY HYPERTENSION IN THE SETTING OF HEREDITARY HEMORRHAGIC TELANGIECTASIA (2015) (0)
- Determinants of Health-Related Quality of Life as Assessed by the PAH-SYMPACT Questionnaire in Patients with Pulmonary Arterial Hypertension (2020) (0)
- Cardiac index and hepatopulmonary syndrome in liver transplantation candidates: The pulmonary vascular complications of liver disease study (2023) (0)
- Syndrome* Current Concepts in Diagnostic and Therapeutic Considerations (2017) (0)
- Do Late Bubbles Correspond to Early Hepatopulmonary Syndrome? (2017) (0)
- Feedback from admission committees to applicant interviewers. (1978) (0)
- communications tothe editor (2017) (0)
- Prevalence and Implications of Positive Contrast Transthoracic Echocardiography in Portopulmonary Hypertension (2013) (0)
- Table of Contents (2020) (0)
- Smoking and Outcomes in Candidates for Liver Transplantation: PVCLD2 (2023) (0)
- Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database (2020) (0)
- Temporal Trends in Portopulmonary Hypertension (POPH) Model for End Stage Liver Disease (MELD) Exceptions (2022) (0)
- Resolution of portopulmonary hypertension (POPH) following liver transplantation (2012) (0)
- The Utility of Serial Right Heart Catheterizations in Patients with Model for End Stage Liver Disease Exceptions for Portopulmonary Hypertension (0)
- Pulmonary alveolar proteinosis clinico-Pathologic conferences (2012) (0)
- Review of Portopulmonary Hypertension Prevalence at Mayo Clinic in Arizona, Florida, and Minnesota (2023) (0)
- Hemodynamic Response to Inhaled Nitric Oxide in Patients with Pulmonary Hypertension and Chronic Kidney Disease: A Retrospective Cohort Study (2022) (0)
- Chapter 59 – Hepatic and Biliary Disease (2008) (0)
- Plasma Endothelin-1 And Pulmonary Vascular Complications Of Liver Disease (2010) (0)
- 717: ASSOCIATION OF PULMONARY HYPERTENSION AND MORTALITY IN PATIENTS WITH VENTILATOR ASSOCIATED EVENTS (2014) (0)
This paper list is powered by the following services: